Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ ATPase Na+/K+ beta 3 Human Recombinant Protein
SDP

Catalog No. p-7104589 Shop All Novus Biologicals Products
Click to view available options
Quantity:
0.05mg
0.25 mg

Highly purified. Generating reliable and reproducible results.

A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 57- 279 of Human ATPase Na+/K+ beta 3 The Recombinant Human ATPase Na+/K+ beta 3 Protein is derived from E. coli. The Recombinant Human ATPase Na+/K+ beta 3 Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 0.25mg/mL
For Use With (Application) SDS-Page
Formulation 20mM Tris-HCl buffer (pH 8.0) containing 20% glycerol, 0.15M NaCl, 1mM DTT
Gene ID (Entrez) 483
Molecular Weight (g/mol) TMW: 27.4kDa
Purity >80%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain
Quantity 0.05mg
Storage Requirements Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
Gene Alias ATPase, Na+/K+ transporting, beta 3 polypeptide, ATPB-3, CD298, CD298 antigen, FLJ29027, Na, K-ATPase beta-3 polypeptide, sodium/potassium-dependent ATPase beta-3 subunit, Sodium/potassium-dependent ATPase subunit beta-3, sodium/potassium-transporting ATPase beta-3 chain, sodium/potassium-transporting ATPase subunit beta-3
Common Name ATPase Na+/K+ beta 3
Conjugate Unlabeled
Recombinant Yes
Show More Show Less

For research use only and is not approved for use in humans or in clinical diagnosis

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.